CLX
Get informed when a big investor buys or sells
+ FollowOctober 30, 2024 - AI Summary
Undervalued by 79.9% based on the discounted cash flow analysis.
| Market cap | $12.71 Billion |
|---|---|
| Enterprise Value | $18.09 Billion |
| Dividend Yield | $4.96 (4.72%) |
| Earnings per Share | $4.82 |
| Beta | 0.53 |
| Outstanding Shares | 121,775,000 |
| P/E Ratio | 21.82 |
|---|---|
| PEG | -42.86 |
| Price to Sales | 1.94 |
| Price to Book Ratio | 53.27 |
| Enterprise Value to Revenue | 2.69 |
| Enterprise Value to EBIT | 19.39 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 61.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2774▼ 40.03% |
|---|---|
| Total Calls | 99,500▼ 96.09% |
| Total Puts | 27,600▼ 98.40% |
Holdings and activity of institutional investors.
| Ownership % | 29.56%▼ 52.47% |
|---|---|
| Total Invested | $3.58B▼ 65.25% |
| Investors Holding | 606▼ 517.00% |
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...